TA-MSCs can secrete a large amount of CXCL12 to activate the overexpressed specific receptor CXCR4 on AML cells, thereby guiding AML cells to migrate to the BMME and acquire drug resistance signals (196). Here, CXCL12 is linked to acute myeloid leukemia.